Rabbit anti-IL-2 Recombinant Monoclonal Antibody

<strong>Rabbit anti-IL-2 Recombinant Monoclonal Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2014921_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 20 uL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> aldesleukin;IL-2;lymphokine;T cell growth factor;T-cell growth factor;TCGF_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Di Filippo S. Anti-IL-2 receptor antibody vs. polyclonal anti-lymphocyte antibody as induction therapy in pediatric transplantation Pediatr Transplant. 2005 Jun;9(3):373-80._x000D_ 2: Spiegelberg HL, Falkoff RJ, O'Connor RD, Beck L. Interleukin-2 inhibits the interleukin-4-induced human IgE and IgG4 secretion in vivo Clin Exp Immunol. 1991 Jun;84(3):400-5._x000D_ 3: Lagoo A, Tseng CK, Sell S. Interleukin 2 produced by activated B lymphocytes acts as an autocrine proliferation-inducing lymphokine Cytokine. 1990 Jul;2(4):272-9._x000D_ 4: Woodside KJ, Hu M, Meng T, Hunter GC, Sower LE, Daller JA. Differential effects of interleukin-2 blockade on apoptosis in naïve and activated human lymphocytes Transplantation. 2003 May 27;75(10):1631-5._x000D_ 5: Miyamoto T, Lillehoj HS, Sohn EJ, Min W. Production and characterization of monoclonal antibodies detecting chicken interleukin-2 and the development of an antigen capture enzyme-linked immunosorbent assay Vet Immunol Immunopathol. 2001 Aug 10;80(3-4):245-57._x000D_ 6: Oudrhiri N, Farcet JP, Gourdin MF, Divine M, Marolleau JP, Bouguet J, Le Couedic JP, Shaw A, Fradelizi D, Reyes F. Activation by PHA of CD8 lymphocytes into clonal colony forming cells. Role of interleukin-1 J Immunol Methods. 1988 Jun 13;110(2):241-9._x000D_ 7: Goh BK, Chedid MF, Gloor JM, Raghavaiah S, Stegall MD. The impact of terminal complement blockade on the efficacy of induction with polyclonal rabbit antithymocyte globulin in living donor renal allografts Transpl Immunol. 2012 Oct;27(2-3):95-100._x000D_ 8: Ruggenenti P, Codreanu I, Cravedi P, Perna A, Gotti E, Remuzzi G. Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: a possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantation Clin J Am Soc Nephrol. 2006 May;1(3):546-54._x000D_ 9: Longuet H, Sautenet B, Gatault P, Thibault G, Barbet C, Marliere JF, Halimi JM, Lebranchu Y, Baron C, Büchler M. Risk factors for impaired CD4+ T-cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantation Transpl Int. 2014 Mar;27(3):271-9._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/8610379">10: Nashan B, Schlitt HJ, Schwinzer R, Ringe B, Kuse E, Tusch G, Wonigeit K, Pichlmayr R. Immunoprophylaxis with a monoclonal anti-IL-2 receptor antibody in liver transplant patients Transplantation. 1996 Feb 27;61(4):546-54. </a>_x000D_ _x000D_ <strong>Products Related to Rabbit anti-IL-2 Recombinant Monoclonal Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>